Holen Sie sich die Stockscreener-App
5.87
11.46%
-0.76
Handel nachbörslich:
5.71
-0.16
-2.73%
Schlusskurs vom Vortag:
$6.63
Offen:
$6.58
24-Stunden-Volumen:
89,861
Relative Volume:
0.75
Marktkapitalisierung:
$176.81M
Einnahmen:
$8.98M
Nettoeinkommen (Verlust:
$-31.39M
KGV:
-4.3806
EPS:
-1.34
Netto-Cashflow:
$-24.83M
1W Leistung:
+3.44%
1M Leistung:
+51.68%
6M Leistung:
+30.88%
1J Leistung:
-21.52%
1-Tages-Spanne:
$5.72
$6.70
1-Wochen-Bereich:
$5.51
$7.17
52-Wochen-Spanne:
$3.76
$9.17
Profound Medical Corp Stock (PROF) Company Profile
Firmenname
Profound Medical Corp
Sektor
Branche
Telefon
647-476-1350
Adresse
2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON
Vergleichen Sie PROF mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PROF
Profound Medical Corp
|
5.87 | 199.25M | 8.98M | -31.39M | -24.83M | -1.34 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Profound Medical Corp Stock (PROF) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-23 | Eingeleitet | Lake Street | Buy |
| 2024-07-16 | Hochstufung | Stifel | Hold → Buy |
| 2023-11-28 | Eingeleitet | Stifel | Hold |
| 2023-08-04 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-03-21 | Herabstufung | Jefferies | Buy → Hold |
| 2020-09-15 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Profound Medical Corp Aktie (PROF) Neueste Nachrichten
What Fibonacci levels say about Profound Medical Corp. reboundJuly 2025 Recap & Accurate Buy Signal Notifications - newser.com
Using economic indicators to assess Profound Medical Corp. potentialJuly 2025 Volume & Low Drawdown Investment Ideas - newser.com
(PRN) Strategic Market Analysis (PRN:CA) - news.stocktradersdaily.com
Technical signs of recovery in Profound Medical Corp.July 2025 News Drivers & Expert Verified Stock Movement Alerts - newser.com
Should you hold or exit Profound Medical Corp. nowM&A Rumor & AI Driven Stock Reports - newser.com
Profound Medical Corp. stock trendline breakdown2025 Stock Rankings & AI Forecasted Stock Moves - newser.com
What risks investors should watch in Profound Medical Corp. stockWeekly Investment Recap & Technical Pattern Based Signals - newser.com
Profound Medical Corp. Hits Day High with Strong 10.71% Surge - Markets Mojo
Great week for Profound Medical Corp. (TSE:PRN) institutional investors after losing 17% over the previous year - simplywall.st
Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter - Investing News Network
PROF Projects Significant Gross Margin Growth in Q3 2025 - GuruFocus
Profound Medical Reports Record Preliminary Q3 2025 Revenue - TipRanks
(PRN) Investment Analysis and Advice (PRN:CA) - news.stocktradersdaily.com
Combining machine learning predictions for Profound Medical Corp.Forecast Cut & Growth-Oriented Investment Plans - newser.com
What technical charts say about Profound Medical Corp. stock2025 AllTime Highs & Smart Allocation Stock Tips - newser.com
What analysts say about Profound Medical Corp stockWeekly Market Snapshot & Free Stock Index Interpretations - earlytimes.in
3 Canadian Stocks That Could Turn $10,000 Into $100,000 - Yahoo
Profound Medical Announces First Quarter 2025 Financial Results - ADVFN
(PRN) Investment Strategy and Analysis (PRN:CA) - news.stocktradersdaily.com
What drives Profound Medical Corp stock priceTrade Execution Strategies & Minimal Investment Portfolio Growth - earlytimes.in
Raymond James Sticks to Their Buy Rating for Profound Medical (PRN) - The Globe and Mail
Profound Medical stock rating reiterated at Outperform by Raymond James By Investing.com - Investing.com Nigeria
Profound Medical: Expectations Worsen (NASDAQ:PROF) - Seeking Alpha
Profound Medical rises as TULSA procedure launched at Dallas Medical Center - MSN
Profound Medical stock rating reiterated at Outperform by Raymond James - Investing.com India
Can Profound Medical Deliver Over 70% Revenue Growth In 2025? - RTTNews
Profound Medical Expands TULSA Program in Texas, Enhancing Prostate Treatment Access - MSN
Profound Medical Corp. (TSE:PRN) is favoured by institutional owners who hold 51% of the company - Yahoo Finance
Profound Medical (PROF) Gains as Dallas Center Launches TULSA Pr - GuruFocus
Profound Medical Says First Tulsa Program for Prostate Treatment Launched in Texas; Shares Rise - MarketScreener
Profound Medical gains on TULSA launch in Dallas (PROF) - Seeking Alpha
Profound Medical (PROF) Expands Prostate Treatment with TULSA Pr - GuruFocus
First-Ever Medicare TULSA Program: Profound Medical Brings AI-Powered Prostate Treatment to Dallas Patients - Stock Titan
Visual analytics tools that track Profound Medical Corp. performanceJuly 2025 Short Interest & AI Enhanced Execution Alerts - newser.com
Finanzdaten der Profound Medical Corp-Aktie (PROF)
Umsatz
Nettogewinn
Free Cashflow
ENV
Profound Medical Corp-Aktie (PROF) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Menawat Arun Swarup | CEO |
May 15 '25 |
Buy |
4.33 |
10,003 |
43,263 |
575,062 |
1.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):